| |
| |
|
| Insider
Information: |
Mohindru Mani |
| Relationship: |
CFO & Chief Strategy O... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
17,441 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,177 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
17,441 |
|
|
| Total
Value |
$13,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
CFO & Chief Strategy O... |
2019-12-04 |
17,441 |
2018-10-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-12-04 |
4 |
AS |
$17.05 |
$81,073 |
D/D |
(4,755) |
17,441 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
22,196 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-07-15 |
4 |
AS |
$25.00 |
$935,775 |
D/D |
(37,431) |
13,863 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-07-15 |
4 |
OE |
$14.06 |
$526,280 |
D/D |
37,431 |
51,294 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-05-29 |
4 |
AS |
$21.39 |
$53,389 |
D/D |
(2,496) |
13,863 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
16,359 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-03-13 |
4 |
OE |
$14.06 |
$225,536 |
D/D |
16,041 |
24,067 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2019-03-13 |
4 |
AS |
$19.12 |
$306,704 |
D/D |
(16,041) |
8,026 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-12-28 |
4 |
AS |
$12.55 |
$56,475 |
D/D |
(4,500) |
8,026 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,526 |
12,526 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-11-15 |
4 |
AS |
$18.50 |
$296,777 |
D/D |
(16,042) |
0 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-11-15 |
4 |
OE |
$14.06 |
$225,551 |
D/D |
16,042 |
16,042 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-10-17 |
4 |
AS |
$20.19 |
$323,888 |
D/D |
(16,042) |
0 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
CFO & Chief Strategy Officer |
• – – |
2018-10-17 |
4 |
OE |
$14.06 |
$225,551 |
D/D |
16,042 |
16,042 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
